Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Elys BMG Group, Inc. stock logo
ELYS
Elys BMG Group
$0.00
$0.00
$0.00
$0.75
$4K11.933,297 shs104 shs
Grom Social Enterprises, Inc. stock logo
GROM
Grom Social Enterprises
$0.00
$0.00
$0.00
$1K1.5583,705 shsN/A
Kubient, Inc. stock logo
KBNT
Kubient
$0.00
$0.00
$0.01
$1K0.83,705 shsN/A
Kaleido Biosciences, Inc. stock logo
KLDO
Kaleido Biosciences
$0.00
-66.7%
$0.00
$0.00
$0.35
$4K-0.062,269 shs1,000 shs
Don't Wait for the OpenAI IPO Cover

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Elys BMG Group, Inc. stock logo
ELYS
Elys BMG Group
0.00%0.00%-66.67%0.00%-75.00%
Grom Social Enterprises, Inc. stock logo
GROM
Grom Social Enterprises
0.00%0.00%-50.00%-50.00%-88.89%
Kubient, Inc. stock logo
KBNT
Kubient
0.00%0.00%0.00%0.00%0.00%
Kaleido Biosciences, Inc. stock logo
KLDO
Kaleido Biosciences
-66.67%0.00%0.00%0.00%0.00%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Elys BMG Group, Inc. stock logo
ELYS
Elys BMG Group
$0.00
$0.00
$0.00
$0.75
$4K11.933,297 shs104 shs
Grom Social Enterprises, Inc. stock logo
GROM
Grom Social Enterprises
$0.00
$0.00
$0.00
$1K1.5583,705 shsN/A
Kubient, Inc. stock logo
KBNT
Kubient
$0.00
$0.00
$0.01
$1K0.83,705 shsN/A
Kaleido Biosciences, Inc. stock logo
KLDO
Kaleido Biosciences
$0.00
-66.7%
$0.00
$0.00
$0.35
$4K-0.062,269 shs1,000 shs
Don't Wait for the OpenAI IPO Cover

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Elys BMG Group, Inc. stock logo
ELYS
Elys BMG Group
0.00%0.00%-66.67%0.00%-75.00%
Grom Social Enterprises, Inc. stock logo
GROM
Grom Social Enterprises
0.00%0.00%-50.00%-50.00%-88.89%
Kubient, Inc. stock logo
KBNT
Kubient
0.00%0.00%0.00%0.00%0.00%
Kaleido Biosciences, Inc. stock logo
KLDO
Kaleido Biosciences
-66.67%0.00%0.00%0.00%0.00%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Elys BMG Group, Inc. stock logo
ELYS
Elys BMG Group
0.00
N/AN/AN/A
Grom Social Enterprises, Inc. stock logo
GROM
Grom Social Enterprises
0.00
N/AN/AN/A
Kubient, Inc. stock logo
KBNT
Kubient
0.00
N/AN/AN/A
Kaleido Biosciences, Inc. stock logo
KLDO
Kaleido Biosciences
0.00
N/AN/AN/A
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Elys BMG Group, Inc. stock logo
ELYS
Elys BMG Group
$43.86M0.00N/AN/AN/A
Grom Social Enterprises, Inc. stock logo
GROM
Grom Social Enterprises
$3.72M0.00N/AN/A$6.25 per share0.00
Kubient, Inc. stock logo
KBNT
Kubient
$1.17M0.00N/AN/AN/ANaN
Kaleido Biosciences, Inc. stock logo
KLDO
Kaleido Biosciences
$1.10M0.00N/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Elys BMG Group, Inc. stock logo
ELYS
Elys BMG Group
-$18.26M-$0.27N/AN/AN/AN/AN/AN/AN/A
Grom Social Enterprises, Inc. stock logo
GROM
Grom Social Enterprises
-$12.53M-$11.67N/AN/AN/AN/AN/AN/AN/A
Kubient, Inc. stock logo
KBNT
Kubient
-$13.62M-$0.17N/AN/AN/AN/AN/AN/AN/A
Kaleido Biosciences, Inc. stock logo
KLDO
Kaleido Biosciences
N/A-$2.24N/AN/AN/AN/AN/AN/AN/A
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Elys BMG Group, Inc. stock logo
ELYS
Elys BMG Group
N/AN/AN/AN/AN/A
Grom Social Enterprises, Inc. stock logo
GROM
Grom Social Enterprises
N/AN/AN/AN/AN/A
Kubient, Inc. stock logo
KBNT
Kubient
N/AN/AN/AN/AN/A
Kaleido Biosciences, Inc. stock logo
KLDO
Kaleido Biosciences
N/AN/AN/AN/AN/A

Institutional Ownership

CompanyInstitutional Ownership
Elys BMG Group, Inc. stock logo
ELYS
Elys BMG Group
N/A
Grom Social Enterprises, Inc. stock logo
GROM
Grom Social Enterprises
15.94%
Kubient, Inc. stock logo
KBNT
Kubient
13.91%
Kaleido Biosciences, Inc. stock logo
KLDO
Kaleido Biosciences
81.56%

Insider Ownership

CompanyInsider Ownership
Elys BMG Group, Inc. stock logo
ELYS
Elys BMG Group
18.48%
Grom Social Enterprises, Inc. stock logo
GROM
Grom Social Enterprises
0.01%
Kubient, Inc. stock logo
KBNT
Kubient
22.33%
Kaleido Biosciences, Inc. stock logo
KLDO
Kaleido Biosciences
9.00%
CompanyEmployeesShares OutstandingFree FloatOptionable
Elys BMG Group, Inc. stock logo
ELYS
Elys BMG Group
9038.81 million31.64 millionNo Data
Grom Social Enterprises, Inc. stock logo
GROM
Grom Social Enterprises
4509.02 million9.02 millionNot Optionable
Kubient, Inc. stock logo
KBNT
Kubient
4014.73 million11.44 millionNo Data
Kaleido Biosciences, Inc. stock logo
KLDO
Kaleido Biosciences
8042.62 million38.79 millionNot Optionable

Recent News About These Companies

Kaleido Biosciences Inc.
Kaleido Biosciences Inc (KLDO)
ViCentra wins CE mark for Kaleido insulin pump
Onyx Boox T10C e-Note With Kaleido 3 Display Launched

New MarketBeat Followers Over Time

Media Sentiment Over Time

Elys BMG Group stock logo

Elys BMG Group NASDAQ:ELYS

$0.0001 0.00 (0.00%)
As of 02:10 PM Eastern

Elys BMG Group, Inc. engages in the provision of business-to-consumer gaming services in the United States and Europe. The company offers betting platform software services to leisure betting establishments; and operates web based and land-based leisure betting establishments. Its gaming product offerings include sports betting; and online casino, such as online slot and table games, poker, bingo, skilled and interactive games, virtual sports betting, and horse racing. It provides its products through physical, land-based retail locations; newgioco.it or commercial webskins linked to its website; and mobile devices. The company was formerly known as Elys Game Technology, Corp. and changed its name to Elys BMG Group, Inc. in January 2024. Elys BMG Group, Inc. was incorporated in 1998 and is based in Toronto, Canada.

Grom Social Enterprises stock logo

Grom Social Enterprises NASDAQ:GROM

Grom Social Enterprises, Inc., through its subsidiaries, operates as a media, technology, and entertainment company in the United States and Philippines. It operates through three segments: Animation, Original Content, and Social and Technology. The company operates a social media network for children under the age of 13 years. It also produces animated films and televisions series; and provides web filtering services to schools and government agencies, as well as acquires, develops, and builds commercial potential of kids and family entertainment properties and associated business opportunities. Grom Social Enterprises, Inc. was founded in 2012 and is headquartered in Boca Raton, Florida.

Kubient stock logo

Kubient NASDAQ:KBNT

Kubient, Inc. develops a cloud-based software platform for digital advertising industry. It develops Audience Marketplace, a platform for real-time trading of digital, programmatic advertising. The company's platform allows advertisers and publishers the ability to use machine learning during programmatic advertising inventory auction. The company was incorporated in 2017 and is based in New York, New York.

Kaleido Biosciences stock logo

Kaleido Biosciences NASDAQ:KLDO

$0.0001 0.00 (-66.67%)
As of 02:27 PM Eastern

Kaleido Biosciences, Inc., a clinical-stage healthcare company, develops microbiome metabolic therapies. The company develops KB195 for the treatment of patients with urea cycle disorder; KB295 to treat ulcerative colitis; KB174 for the treatment of hepatic encephalopathy; and KB109 to treat COVID-19 disease. It also develops programs for the treatment of multi drug resistant infection, chronic kidney disease, atherosclerotic cardiovascular disease, cardio-metabolic syndrome, immuno-oncology, and inflammatory bowel diseases. The company has collaboration agreements with Institute Gustave Roussy, Washington University, and Janssen. Kaleido Biosciences, Inc. was incorporated in 2015 and is headquartered in Lexington, Massachusetts.